Skip to main content

Table 1 Correlation between ALX4 expression and clinical parameters from TMA data

From: ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway

  

ALX4 expression

 

Clinical parameter

Total

High

Low

P value

Clinical stages

   

0.012

I

11

9

2

 

II

81

21

60

 

III

48

12

36

 

Histological grade

   

0.638

1

35

9

26

 

2

106

33

73

 

3

1

0

1

 

Lymph node status

   

0.000

Negative

50

25

25

 

Positive

88

17

71

 

Tumor size

   

0.016

< 3 cm

48

21

27

 

≧3 cm

93

21

72

 

Her2

   

0.264

Positive

43

16

27

 

Negative

88

24

64

 

PR

   

0.058

Positive

77

19

58

 

Negative

52

21

31

 

ER

   

0.975

Positive

88

27

61

 

Negative

42

13

29

 
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us